UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Arginase regulates red blood cell nitric oxide synthase and export of cardioprotective nitric oxide bioactivity

Proceedings of the National Academy of Sciences - PNAS, 2013-09, Vol.110 (37), p.15049-15054

2013

Volltextzugriff (PDF)

Local arginase inhibition during early reperfusion mediates cardioprotection via increased nitric oxide production

PloS one, 2012-07, Vol.7 (7), p.e42038-e42038

2012

Volltextzugriff (PDF)

The role of arginase and rho kinase in cardioprotection from remote ischemic perconditioning in non-diabetic and diabetic rat in vivo

PloS one, 2014-08, Vol.9 (8), p.e104731-e104731

2014

Volltextzugriff (PDF)

Arginase inhibition mediates cardioprotection during ischaemia–reperfusion

Cardiovascular research, 2010-01, Vol.85 (1), p.147-154

2010

Volltextzugriff (PDF)

Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism

Regulatory peptides, 2005-02, Vol.125 (1), p.173-177

2005

Volltextzugriff (PDF)

Involvement of nitric oxide in cardioprotective effect of endothelin receptor antagonist during ischemia-reperfusion

American journal of physiology. Heart and circulatory physiology, 2001-03, Vol.280 (3), p.H1105-H1112

2001

Volltextzugriff (PDF)

Inhibition of Rho kinase protects from ischaemia–reperfusion injury via regulation of arginase activity and nitric oxide synthase in type 1 diabetes

Diabetes & vascular disease research, 2017-05, Vol.14 (3), p.236-245

2017

Volltextzugriff (PDF)

Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide

Cardiovascular research, 2008-04, Vol.78 (1), p.116-122

2008

Volltextzugriff (PDF)

Myocardial protection by co-administration of l -arginine and tetrahydrobiopterin during ischemia and reperfusion

International journal of cardiology, 2013-10, Vol.169 (1), p.83-88

2013

Volltextzugriff (PDF)

Cardioprotection mediated by rosiglitazone, a peroxisome proliferator-activated receptor gamma ligand, in relation to nitric oxide

Basic research in cardiology, 2007-01, Vol.102 (1), p.80-89

2007

Volltextzugriff (PDF)

Opioid receptor agonist Eribis peptide 94 reduces infarct size in different porcine models for myocardial ischaemia and reperfusion

European journal of pharmacology, 2011-01, Vol.651 (1-3), p.146-151

2011

Volltextzugriff (PDF)

Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion

American journal of physiology. Heart and circulatory physiology, 2004-05, Vol.286 (5), p.H1767-H1774

2004

Volltextzugriff (PDF)

Cardioprotective effect of an endothelin receptor antagonist during ischaemia/reperfusion in the severely atherosclerotic mouse heart

British journal of pharmacology, 2005-03, Vol.144 (6), p.860-866

2005

Volltextzugriff (PDF)

Cardioprotective effect induced by brief exposure to nitric oxide before myocardial ischemia–reperfusion in vivo

Nitric oxide, 2002-11, Vol.7 (3), p.210-216

2002

Volltextzugriff (PDF)

The endothelin-1 receptor antagonist bosentan protects against ischaemia/reperfusion-induced endothelial dysfunction in humans

Clinical science (1979), 2005-04, Vol.108 (4), p.357

2005

Volltextzugriff (PDF)

Cardioprotection from Ischemia and Reperfusion Injury by an Endothelin A-Receptor Antagonist in Relation to Nitric Oxide Production

Journal of cardiovascular pharmacology, 2000-09, Vol.36 (3), p.405-412

2000

Volltextzugriff (PDF)

Limitation of infarct size and attenuation of myeloperoxidase activity by an endothelin A receptor antagonist following ischaemia and reperfusion

Basic research in cardiology, 2001-09, Vol.96 (5), p.454-462

2001

Volltextzugriff (PDF)

Cardioprotection mediated by rosiglitazone, a peroxisome proliferatoractivated receptor gamma ligand, in relation to nitric oxide

Basic research in cardiology, 2007-01, Vol.102 (1), p.80-89

2007

Volltextzugriff (PDF)

The endothelin a receptor antagonist LU 135252 protects the myocardium from neutrophil injury during ischaemia/reperfusion

Cardiovascular research, 1998-09, Vol.39 (3), p.674-682

1998

Volltextzugriff (PDF)

Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion

American journal of physiology. Heart and circulatory physiology, 2004-05, Vol.55 (5), p.H1767-H1774

2004

Volltextzugriff (PDF)

Involvement of nitric oxide in cardioprotective effect of endothelin receptor antagonist during ischemia-reperfusion

American journal of physiology. Heart and circulatory physiology, 2001-03, Vol.49 (3), p.H1105-H1112

2001

Volltextzugriff (PDF)

Myocardial perfusion imaging performed by dedicated cardiac cadmium-zinc-telluride camera in dextrocardia with situs inversus: A case report

Journal of nuclear cardiology, 2022-12, Vol.29 (6), p.3599-3603

2022

Volltextzugriff (PDF)

Arginase inhibition reduces infarct size via nitric oxide, protein kinase C epsilon and mitochondrial ATP-dependent K+ channels

European journal of pharmacology, 2013-07, Vol.712 (1-3), p.16-21

2013

Volltextzugriff (PDF)

Variability in Physical Activity Assessed with Accelerometer Is an Independent Predictor of Mortality in CHF Patients

PloS one, 2016-04, Vol.11 (4), p.e0153036-e0153036

2016

Volltextzugriff (PDF)

Pulmonary volumes and signs of chronic airflow limitation in quantitative computed tomography

Clinical physiology and functional imaging, 2024-07, Vol.44 (4), p.340-348

2024

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(45)
Bücher
(2)
Berichte
(1)

Sprache

Englisch
(48)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Arginase regulates red blood cell nitric oxide synthase and export of cardioprotective nitric oxide bioactivity

Local arginase inhibition during early reperfusion mediates cardioprotection via increased nitric oxide production

The role of arginase and rho kinase in cardioprotection from remote ischemic perconditioning in non-diabetic and diabetic rat in vivo

Arginase inhibition mediates cardioprotection during ischaemia–reperfusion

Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism

Involvement of nitric oxide in cardioprotective effect of endothelin receptor antagonist during ischemia-reperfusion

Inhibition of Rho kinase protects from ischaemia–reperfusion injury via regulation of arginase activity and nitric oxide synthase in type 1 diabetes

Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide

Myocardial protection by co-administration of l -arginine and tetrahydrobiopterin during ischemia and reperfusion

Cardioprotection mediated by rosiglitazone, a peroxisome proliferator-activated receptor gamma ligand, in relation to nitric oxide

Opioid receptor agonist Eribis peptide 94 reduces infarct size in different porcine models for myocardial ischaemia and reperfusion

Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion

Cardioprotective effect of an endothelin receptor antagonist during ischaemia/reperfusion in the severely atherosclerotic mouse heart

Cardioprotective effect induced by brief exposure to nitric oxide before myocardial ischemia–reperfusion in vivo

The endothelin-1 receptor antagonist bosentan protects against ischaemia/reperfusion-induced endothelial dysfunction in humans

Cardioprotection from Ischemia and Reperfusion Injury by an Endothelin A-Receptor Antagonist in Relation to Nitric Oxide Production

Limitation of infarct size and attenuation of myeloperoxidase activity by an endothelin A receptor antagonist following ischaemia and reperfusion

Cardioprotection mediated by rosiglitazone, a peroxisome proliferatoractivated receptor gamma ligand, in relation to nitric oxide

The endothelin a receptor antagonist LU 135252 protects the myocardium from neutrophil injury during ischaemia/reperfusion

Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion

Involvement of nitric oxide in cardioprotective effect of endothelin receptor antagonist during ischemia-reperfusion

Myocardial perfusion imaging performed by dedicated cardiac cadmium-zinc-telluride camera in dextrocardia with situs inversus: A case report

Arginase inhibition reduces infarct size via nitric oxide, protein kinase C epsilon and mitochondrial ATP-dependent K+ channels

Variability in Physical Activity Assessed with Accelerometer Is an Independent Predictor of Mortality in CHF Patients

Pulmonary volumes and signs of chronic airflow limitation in quantitative computed tomography

Suchergebnisse filtern